Male Breast Cancer Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01493310Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerTreatment
NCT02060253Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerTreatment
NCT00004074Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuTreatment
NCT00028535Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid TumorsTreatment
NCT01288261Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast CancerTreatment